A carregar...
Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been attracting attention for cardiovascular as well as antidiabetic effects since the results of the Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME Trial) were reported. The hematocrit in...
Na minha lista:
| Publicado no: | J Clin Med Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elmer Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5087622/ https://ncbi.nlm.nih.gov/pubmed/27829948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2760w |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|